[Cardiovascular morbidity/mortality modified by the use of FGE1 alpha-cyclodextran and calcium heparin in patients with severe vascular diseases].

Source:http://linkedlifedata.com/resource/pubmed/id/10658446

Download in:

View as

General Info

PMID
10658446